星普医科品牌怎么样 申请店铺
始建于1998年,面向全球提供高端大型放疗设备和医疗健康服务的上市公司
广东星普医学科技股份有限公司(以下简称“公司”)成立于1998年,并于2010年12月在深圳证券交易所创业板上市,证券简称“星普医科”,证券代码:300143。
公司目前以大型放疗设备伽玛刀和质子治疗系统制造为基础,不断拓展医疗健康领域业务,形成了目前以提供大型放疗设备与配套解决方案和提供医疗健康服务为主的发展格局。公司总部位于中国广东,在美国、香港、深圳、成都、杭州等地均拥有子公司,并在全球各地设立多个办事机构,已形成完整的研发、生产、营销和服务网络。
作为一家面向全球提供大型放疗设备和医疗健康服务的上市公司,未来公司将充分发挥上市公司在融资渠道和资源整合方面的优势,积极布局医疗健康领域,以发展立体定向放射治疗专用设备和拓展潜力巨大的医疗服务市场为主线,不断推进肿瘤服务领域全产业链的发展,将公司打造成为国内优质肿瘤医疗服务运营商,以良好的业绩、可持续的增长来回报广大股东和投资者,也为人类医疗健康事业做出一份应有的贡献。
Founded in 1998, Guangdong Xingpu medical Polytron Technologies Inc (hereinafter referred to as "the company"), a listed company that provides high-end large-scale radiotherapy equipment and medical and health services to the world, was founded in 1998 and listed on the growth enterprise board of Shenzhen stock exchange in December 2010. The securities are referred to as "Xingpu medical" with the securities code of 300143. At present, based on the manufacturing of large-scale radiotherapy equipment gamma knife and proton therapy system, the company has continuously expanded its business in the field of medical and health care, forming a development pattern focusing on providing large-scale radiotherapy equipment and supporting solutions and providing medical and health services. Headquartered in Guangdong, China, the company has subsidiaries in the United States, Hong Kong, Shenzhen, Chengdu, Hangzhou and other places, and has set up multiple offices around the world, forming a complete R & D, production, marketing and service network. As a listed company providing large-scale radiotherapy equipment and medical and health services to the world, in the future, the company will give full play to the advantages of Listed Companies in financing channels and resource integration, actively layout the field of medical and health care, and constantly promote the whole industry chain of tumor service field with the main line of developing special equipment for stereotactic radiotherapy and expanding the potential medical service market With the development of the company, it will build the company into a domestic high-quality tumor medical service operator, repay the majority of shareholders and investors with good performance and sustainable growth, and also make a due contribution to human medical and health undertakings.
本文链接: https://brand.waitui.com/41ee5452f.html 联系电话:0769-87935678